296 related articles for article (PubMed ID: 30799425)
1. Long Non-Coding RNAs in Thyroid Cancer: Implications for Pathogenesis, Diagnosis, and Therapy.
Mahmoudian-Sani MR; Jalali A; Jamshidi M; Moridi H; Alghasi A; Shojaeian A; Mobini GR
Oncol Res Treat; 2019; 42(3):136-142. PubMed ID: 30799425
[TBL] [Abstract][Full Text] [Related]
2. LncRNAs as Potential Therapeutic Targets in Thyroid Cancer.
Javed Z; Ahmed Shah F; Rajabi S; Raza Q; Iqbal Z; Ullah M; Ahmad T; Salehi B; Sharifi-Rad M; Pezzani R; Yaqoob F; Sadia H; Iriti M; Sharifi-Rad J; Cho WC
Asian Pac J Cancer Prev; 2020 Feb; 21(2):281-287. PubMed ID: 32102500
[TBL] [Abstract][Full Text] [Related]
3. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.
Liao T; Qu N; Shi RL; Guo K; Ma B; Cao YM; Xiang J; Lu ZW; Zhu YX; Li DS; Ji QH
Oncotarget; 2017 Jan; 8(1):238-247. PubMed ID: 27462868
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA BANCR regulates cancer stem cell markers in papillary thyroid cancer via the RAF/MEK/ERK signaling pathway.
Wang Y; Lin X; Fu X; Yan W; Lin F; Kuang P; Luo Y; Lin E; Hong X; Wu G
Oncol Rep; 2018 Aug; 40(2):859-866. PubMed ID: 29917164
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma.
Chu YH; Hardin H; Schneider DF; Chen H; Lloyd RV
Exp Mol Pathol; 2017 Oct; 103(2):229-236. PubMed ID: 29107050
[TBL] [Abstract][Full Text] [Related]
6. Long Non-coding RNA Linc-ROR Is Upregulated in Papillary Thyroid Carcinoma.
Zhang R; Hardin H; Huang W; Buehler D; Lloyd RV
Endocr Pathol; 2018 Mar; 29(1):1-8. PubMed ID: 29280051
[TBL] [Abstract][Full Text] [Related]
7. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
8. The role of long non-coding RNAs in the pathogenesis of thyroid cancer.
Ghafouri-Fard S; Mohammad-Rahimi H; Taheri M
Exp Mol Pathol; 2020 Feb; 112():104332. PubMed ID: 31706987
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.
Ricciuti B; Mencaroni C; Paglialunga L; Paciullo F; Crinò L; Chiari R; Metro G
Med Oncol; 2016 Feb; 33(2):18. PubMed ID: 26786153
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer.
Li Q; Li H; Zhang L; Zhang C; Yan W; Wang C
Oncotarget; 2017 Jul; 8(28):46136-46144. PubMed ID: 28545026
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNAs: emerging players in thyroid cancer pathogenesis.
Murugan AK; Munirajan AK; Alzahrani AS
Endocr Relat Cancer; 2018 Feb; 25(2):R59-R82. PubMed ID: 29146581
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNAs in retinoblastoma.
Yang M; Wei W
Pathol Res Pract; 2019 Aug; 215(8):152435. PubMed ID: 31202519
[TBL] [Abstract][Full Text] [Related]
13. Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer.
Zhao Y; Wang H; Wu C; Yan M; Wu H; Wang J; Yang X; Shao Q
Oncol Rep; 2018 Mar; 39(3):1197-1206. PubMed ID: 29328463
[TBL] [Abstract][Full Text] [Related]
14. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
[TBL] [Abstract][Full Text] [Related]
15. Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer.
Wang Q; Yang H; Wu L; Yao J; Meng X; Jiang H; Xiao C; Wu F
Thyroid; 2016 Dec; 26(12):1719-1732. PubMed ID: 27758138
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance.
Lan X; Sun W; Zhang P; He L; Dong W; Wang Z; Liu S; Zhang H
Tumour Biol; 2016 May; 37(5):6117-23. PubMed ID: 26611646
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNAs in thyroid cancer: Biological functions and clinical significance.
Sui F; Ji M; Hou P
Mol Cell Endocrinol; 2018 Jul; 469():11-22. PubMed ID: 28751134
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of long noncoding RNA MALAT1 in papillary thyroid cancer and its diagnostic value.
Liu J; Dong H; Yang Y; Qian Y; Liu J; Li Z; Guan H; Chen Z; Li C; Zhang K; Zhang Q; Cao W; Lv J
Future Oncol; 2018 Dec; 14(29):3015-3022. PubMed ID: 29987950
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of long noncoding RNA H19 contributes to the proliferation and migration of papillary thyroid carcinoma.
Lan X; Sun W; Dong W; Wang Z; Zhang T; He L; Zhang H
Gene; 2018 Mar; 646():98-105. PubMed ID: 29287713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]